Posted by Michael Wonder on 16 Feb 2021
EMA receives application for conditional marketing authorisation of COVID-19 Vaccine Janssen
16 February 2021 - EMA has received an application for conditional marketing authorisation for a COVID-19 vaccine developed by Janssen-Cilag.
EMA’s CHMP will assess the vaccine, known as COVID-19 Vaccine Janssen, under an accelerated timetable.
